发明名称 NOVEL 3-SUBSTITUTED UREA DERIVATIVES AND MEDICINAL USE THEREOF
摘要 Urea derivatives represented by the following general formula (1) or pharmaceutically acceptable salts thereof: (1) wherein each symbol is as defined in the description. Because of having a C5a receptor antagonism, these compounds are useful as remedies and preventives for diseases or syndromes induced by C5a [for example, autoimmune diseases such as rheumatism and systemic lupus erythematosus, allergic diseases such as sepsis, adult respiratory distress syndrome, chromic obstructive pulmonary disease and asthma, atherosclerosis, cardiac infarction, brain infarction, psoriasis, Alzheimer's disease and serious organ injuries by the activation of leucocytes caused by ischemia, trauma, burn, surgical invasion, etc. (for example, pneumonia, nephritis, hepatitis and pancreatitis)]. Moreover, these compounds are useful as remedies and preventives for bacterial and viral infections mediated by C5a receptor.
申请公布号 WO0214265(A1) 申请公布日期 2002.02.21
申请号 WO2001JP06902 申请日期 2001.08.10
申请人 WELFIDE CORPORATION;ISHIBUCHI, SEIGO;SUMICHIKA, HIROSHI;ITOH, KATSUHIKO;NAKA, YOICHI 发明人 ISHIBUCHI, SEIGO;SUMICHIKA, HIROSHI;ITOH, KATSUHIKO;NAKA, YOICHI
分类号 A61K31/17;A61P9/10;A61P11/00;A61P11/06;A61P17/02;A61P17/06;A61P25/28;A61P31/04;A61P31/12;A61P37/06;A61P37/08;C07C275/28;C07C275/30;C07C275/34;C07C275/40;C07C275/42;C07C323/43;C07C323/44;C07D209/14;C07D213/64;C07D231/12;C07D295/135;C07D317/58;C07D401/06;(IPC1-7):C07C275/28;C07D295/12;A61K31/216;A61K31/235;A61K31/275;A61K31/36;A61K31/404;A61K31/415;A61K31/44;A61K31/443;A61K31/537 主分类号 A61K31/17
代理机构 代理人
主权项
地址